Guochang Wang

发表

Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients

H. Kung, Zhaohui Zhu, Lin Zhu, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

68Ga-NOTA-FAPI-04 PET/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [18F] FDG PET/CT

Xue-juan Wang, Hua Zhu, Zhi Yang, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma

Zhaohui Zhu, Xiaoyu Chen, Xiaoyuan Chen, 2022, EJNMMI Research.

A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours

Zhaohui Zhu, Yuanyuan Jiang, Guochang Wang, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators.

H. Kung, Zhaohui Zhu, Lin Zhu, 2021, Nuclear medicine and biology.

Head-to-Head Comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer

H. Kung, Zhaohui Zhu, Lin Zhu, 2023, Clinical nuclear medicine.

Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CT

Xue-juan Wang, Y. Lai, Zhi Yang, 2021, The Journal of Nuclear Medicine.

Evaluation of Safety, Biodistribution, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177Lu-DOTA-EB-TATE With and Without Amino Acid Infusion

Zhaohui Zhu, Jingjing Zhang, Yuanyuan Jiang, 2023, Clinical nuclear medicine.

A Single-Arm, Low-Dose, Prospective Study of 177Lu-EB-PSMA Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

Zhaohui Zhu, Jingjing Zhang, Xinrong Fan, 2022, The Journal of Nuclear Medicine.

Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors

Zhaohui Zhu, Jingjing Zhang, Yuanyuan Jiang, 2022, Theranostics.

Head-to-head comparison of [^68Ga]Ga-P16-093 and 2-[^18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study

H. Kung, Zhaohui Zhu, Xinrong Fan, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer

H. Kung, Zhaohui Zhu, J. Zang, 2023, European Journal of Nuclear Medicine and Molecular Imaging.

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer.

Wei-bing Miao, Huipan Liu, Haojun Chen, 2023, European journal of nuclear medicine and molecular imaging.

Head-to-head comparison of [68 Ga]Ga-P16-093 and [68 Ga]Ga-PSMA-617 in dynamic PET/CT evaluation of the same group of recurrent prostate cancer patients

H. Kung, Zhaohui Zhu, Xinrong Fan, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Head-to-Head Comparison of 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT in Patients With Primary Prostate Cancer

Yunliang Gao, Jin-rui Yang, Jinfeng Wu, 2023, Clinical nuclear medicine.

Comparison of novel PSMA-targeting [177Lu]Lu-P17-087 with its albumin binding derivative [177Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study.

K. Ploessl, Guochang Wang, Haiyan Hong, 2024, European journal of nuclear medicine and molecular imaging.

Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT

Xue-juan Wang, Xiaodong Jin, Y. Lai, 2023, The Journal of Nuclear Medicine.